Global Recombinant Dna Technology Market Key Players Competitive Survey Report 2023

Report ID: ARS3288 | Category: TECHNOLOGY & MEDIA | Pages: 125 | Format: PDF | Published Date: September 07,2023

Request Sample Enquiry before buying Ask For Discount

Single User-$3650.00 Multi User-$6200.00

Report Description
View Table of Contents

Report Summary

The global Recombinant Dna Technology market size in 2022 is 152790.0 million US dollars, and it is expected to be XX million US dollars by 2029, with a compound annual growth rate of 7.60% expected in 2023-2029.

MARKET COMPETITIVE LANDSCAPE:
The main players in the Recombinant Dna Technology market include F. Hoffmann-La Roche Ltd (Genentech Inc), Profacgen, Amgen Inc, Novartis AG, and GenScript. The share of the top 3 players in the Recombinant Dna Technology market is XX%.

REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of Recombinant Dna Technology market, and Asia Pacific accounted for XX%.

SEGMENT OVERVIEW:
The report segments the market by Type and Application. Medical accounted for XX% of Recombinant Dna Technology market in 2022. Non-Medical share of XX%.
Food & Agriculture accounted for XX% of the Recombinant Dna Technology market in 2022. Health & Disease accounts for XX%.

Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

COVID-19 Impact:
Outbreak of COVID-19 pandemic due to lockdown restrictions imposed by governments around the world has affected the growth of the global Recombinant Dna Technology market in 2020. The containment measures taken by the governments of various countries in response to control the outbreak of COVID-19 disrupted the entire supply chain by creating logistical interruptions, transportation restrictions, and product supply across borders.

The report analyzes the key trends in each segment of the global Recombinant Dna Technology market along with global and country-level forecasts from 2023 to 2028. Our report segments the market based on types and applications, thereby providing a detailed analysis of the market to help gain an in-depth understanding of the market and enable market participants, stakeholders, investors, etc. to have a clearer understanding of the market and judgment.

Key benefits to stakeholders:
The report provides a comprehensive quantitative analysis of various segments, historical and current market trends, market forecasts, and dynamics of the Recombinant Dna Technology market for 2017-2028.
The research report provides the latest information on the market drivers, challenges and opportunities of the global Recombinant Dna Technology market.
The study profiles the leading as well as the fastest growing regional markets. It further enables stakeholders to identify key country-level markets within each region.
Porter's Five Forces Analysis helps stakeholders assess the impact of new entrants, competitors, supplier strength, buyer strength, and threat of substitution. It helps stakeholders analyze the level of competition in the Recombinant Dna Technology industry and its attractiveness.
The competitive landscape enables stakeholders to understand their competitive environment and gain insight into the current position of the key players in the market.

In the past few years, the Information Technology (IT) and Telecommunication industry has witnessed significant developments across various fronts.

5G Technology: The deployment of 5G networks has gained momentum globally. 5G offers faster speeds, lower latency, and increased network capacity compared to its predecessors, enabling transformative applications such as autonomous vehicles, Internet of Things (IoT) devices, augmented reality, and virtual reality.

Cybersecurity: With the rise in cyber threats, cybersecurity has become a critical focus area. New approaches to security, such as advanced encryption, behavioral analytics, and threat intelligence, are being implemented to protect data, networks, and systems. Additionally, privacy regulations like the EU's General Data Protection Regulation (GDPR) have prompted increased attention to data protection.

The industry continues to grow at a rapid pace, driven by the increasing integration of innovation and technology into every aspect of consumers' lives.

Highlights-Regions

North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Spain
Nordic
Asia Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Latin America
Brazil
Mexico
Argentina
Middle East & Africa
Egypt
South Africa
UAE
Turkey
Saudi Arabia

Player list
F. Hoffmann-La Roche Ltd (Genentech Inc)
Profacgen
Amgen Inc
Novartis AG
GenScript
Pfizer Inc
Novo Nordisk A/S
Eli Lilly and Company
Sanofi Merck & Co. Inc.
Biogen
Biocon

Types list
Medical
Non-Medical

Application list
Food & Agriculture
Health & Disease
Environment

Table of Content

1 Recombinant Dna Technology Market Introduction and Overview
1.1 Recombinant Dna Technology Definition
1.2 Research Purposes
1.3 Report Timeline
1.4 Economic Analysis of Global Regions
1.5 Inflation Analysis
1.6 The Impact of the Russian-Ukrainian War on the Market
1.7 Coronavirus Disease 2020 (COVID-19) Impact on Global
2 Global Recombinant Dna Technology Historical Market Analysis by Type
2.1 Market Size Analysis by Types
2.2 Global Recombinant Dna Technology Revenue and Market Share by Type
3 Global Recombinant Dna Technology Historical Market Analysis by Application
3.1 Market Size Analysis by Application
3.2 Global Recombinant Dna Technology Revenue Market Share by Application (2018-2023)
4 Global Market Growth Trends Analysis
4.1 Global Recombinant Dna Technology Market Size (2018-2023)
4.2 Recombinant Dna Technology Growth Trends Analysis by Regions
4.2.1 Recombinant Dna Technology Market Size by Regions: 2018 VS 2023 VS 2029
4.2.2 Recombinant Dna Technology Historic Revenue Market Size by Regions (2018-2023)
4.2.3 North America Recombinant Dna Technology Market Size (2018-2023)
4.2.4 Europe Recombinant Dna Technology Market Size (2018-2023)
4.2.5 Asia-Pacific Recombinant Dna Technology Market Size (2018-2023)
4.2.6 Latin America Recombinant Dna Technology Market Size (2018-2023)
4.2.7 Middle East & Africa Recombinant Dna Technology Market Size (2018-2023)
5 North America
5.1 North America Recombinant Dna Technology Revenue by Countries
5.1.1 North America Recombinant Dna Technology Revenue by Countries (2018-2023)
5.2 North America Recombinant Dna Technology Revenue by Types
5.3 North America Recombinant Dna Technology Revenue by Applications
5.4 United States
5.5 Canada
6 Asia Pacific
6.1 Asia Pacific Recombinant Dna Technology Revenue by Countries
6.1.1 Asia Pacific Recombinant Dna Technology Revenue by Countries (2018-2023)
6.2 Asia Pacific Recombinant Dna Technology Revenue by Types
6.3 Asia Pacific Recombinant Dna Technology Revenue by Applications
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Recombinant Dna Technology Revenue by Countries
7.1.1 Europe Recombinant Dna Technology Revenue by Countries (2018-2023)
7.2 Europe Recombinant Dna Technology Revenue by Types
7.3 Europe Recombinant Dna Technology Revenue by Applications
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Nordic
8 Latin America
8.1 Latin America Recombinant Dna Technology Revenue by Countries
8.1.1 Latin America Recombinant Dna Technology Revenue by Countries (2018-2023)
8.2 Latin America Recombinant Dna Technology Revenue by Types
8.3 Latin America Recombinant Dna Technology Revenue by Applications
8.4 Brazil
8.5 Argentina
8.6 Mexico
9 Middle East & Africa
9.1 Middle East & Africa Recombinant Dna Technology Revenue by Countries
9.1.1 Middle East & Africa Recombinant Dna Technology Revenue by Countries (2018-2023)
9.2 Middle East & Africa Recombinant Dna Technology Revenue by Types
9.3 Middle East & Africa Recombinant Dna Technology Revenue by Applications
9.4 Egypt
9.5 South Africa
9.6 UAE
9.7 Turkey
9.8 Saudi Arabia
10 Global Recombinant Dna Technology Market Competition, by Players
10.1 Global Recombinant Dna Technology Revenue and Market Share by Players
10.2 Market Concentration Rate
10.2.1 Top 3 Recombinant Dna Technology Players Market Share in 2022
10.2.2 Top 6 Recombinant Dna Technology Players Market Share in 2022
10.2.3 Market Competition Trend
10.3 Recombinant Dna Technology Players Head Office, Business Provided
10.4 Recombinant Dna Technology Mergers & Acquisitions
10.5 Recombinant Dna Technology New Entrants and Expansion Plans
11 Players Profiles11.1 F. Hoffmann-La Roche Ltd (Genentech Inc)
11.1.1 F. Hoffmann-La Roche Ltd (Genentech Inc) Company Profile
11.1.2 Recombinant Dna Technology Product Overview
11.1.3 F. Hoffmann-La Roche Ltd (Genentech Inc) Recombinant Dna Technology Market Performance (2018-2023)
11.1.4 F. Hoffmann-La Roche Ltd (Genentech Inc) Business Overview
11.1.5 Recent Developments and Plans
11.2 Profacgen
11.2.1 Profacgen Company Profile
11.2.2 Recombinant Dna Technology Product Overview
11.2.3 Profacgen Recombinant Dna Technology Market Performance (2018-2023)
11.2.4 Profacgen Business Overview
11.2.5 Recent Developments and Plans
11.3 Amgen Inc
11.3.1 Amgen Inc Company Profile
11.3.2 Recombinant Dna Technology Product Overview
11.3.3 Amgen Inc Recombinant Dna Technology Market Performance (2018-2023)
11.3.4 Amgen Inc Business Overview
11.3.5 Recent Developments and Plans
11.4 Novartis AG
11.4.1 Novartis AG Company Profile
11.4.2 Recombinant Dna Technology Product Overview
11.4.3 Novartis AG Recombinant Dna Technology Market Performance (2018-2023)
11.4.4 Novartis AG Business Overview
11.4.5 Recent Developments and Plans
11.5 GenScript
11.5.1 GenScript Company Profile
11.5.2 Recombinant Dna Technology Product Overview
11.5.3 GenScript Recombinant Dna Technology Market Performance (2018-2023)
11.5.4 GenScript Business Overview
11.5.5 Recent Developments and Plans
11.6 Pfizer Inc
11.6.1 Pfizer Inc Company Profile
11.6.2 Recombinant Dna Technology Product Overview
11.6.3 Pfizer Inc Recombinant Dna Technology Market Performance (2018-2023)
11.6.4 Pfizer Inc Business Overview
11.6.5 Recent Developments and Plans
11.7 Novo Nordisk A/S
11.7.1 Novo Nordisk A/S Company Profile
11.7.2 Recombinant Dna Technology Product Overview
11.7.3 Novo Nordisk A/S Recombinant Dna Technology Market Performance (2018-2023)
11.7.4 Novo Nordisk A/S Business Overview
11.7.5 Recent Developments and Plans
11.8 Eli Lilly and Company
11.8.1 Eli Lilly and Company Company Profile
11.8.2 Recombinant Dna Technology Product Overview
11.8.3 Eli Lilly and Company Recombinant Dna Technology Market Performance (2018-2023)
11.8.4 Eli Lilly and Company Business Overview
11.8.5 Recent Developments and Plans
11.9 Sanofi Merck & Co. Inc.
11.9.1 Sanofi Merck & Co. Inc. Company Profile
11.9.2 Recombinant Dna Technology Product Overview
11.9.3 Sanofi Merck & Co. Inc. Recombinant Dna Technology Market Performance (2018-2023)
11.9.4 Sanofi Merck & Co. Inc. Business Overview
11.9.5 Recent Developments and Plans
11.10 Biogen
11.10.1 Biogen Company Profile
11.10.2 Recombinant Dna Technology Product Overview
11.10.3 Biogen Recombinant Dna Technology Market Performance (2018-2023)
11.10.4 Biogen Business Overview
11.10.5 Recent Developments and Plans
11.11 Biocon
11.11.1 Biocon Company Profile
11.11.2 Recombinant Dna Technology Product Overview
11.11.3 Biocon Recombinant Dna Technology Market Performance (2018-2023)
11.11.4 Biocon Business Overview
11.11.5 Recent Developments and Plans
12 Global Recombinant Dna Technology Forecast Market Analysis by Type
12.1 Global Recombinant Dna Technology Revenue Market Forecast by Type (2023-2029)
13 Global Recombinant Dna Technology Forecast Market Analysis by Application
13.1 Recombinant Dna Technology Revenue Market Forecast by Application (2023-2029)
14 Global Market Growth Forecast Analysis
14.1 Global Recombinant Dna Technology Forecast Market Size (2023-2029)
14.2 Recombinant Dna Technology Growth Trends Forecast Analysis by Regions
14.2.1 Recombinant Dna Technology Revenue Forecast Market Size by Regions (2023-2029)
14.2.2 North America Recombinant Dna Technology Forecast Market Size (2023-2029)
14.2.3 Europe Recombinant Dna Technology Forecast Market Size (2023-2029)
14.2.4 Asia-Pacific Recombinant Dna Technology Forecast Market Size (2023-2029)
14.2.5 Latin America Recombinant Dna Technology Forecast Market Size (2023-2029)
14.2.6 Middle East & Africa Recombinant Dna Technology Forecast Market Size (2023-2029)
15 Recombinant Dna Technology Industry Dynamic Analysis
15.1 Recombinant Dna Technology Market Trends Analysis
15.2 Recombinant Dna Technology Market Drivers Analysis
15.3 Recombinant Dna Technology Market Challenges Analysis
15.4 Recombinant Dna Technology Market Restraints Analysis

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Global Recombinant Dna Technology Market Key Players Competitive Survey Report 2023

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?